Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

Chiara Naro (Creatore)
Ambra Antonioni (Creatore)
Vanessa Medici (Creatore)
Cinzia Caggiano (Creatore)
Ariane Jolly (Creatore)
Pierre de la Grange (Creatore)
Pamela Bielli (Creatore)
Maria Paola Paronetto (Creatore)
Claudio Sette (Creatore)

Dataset

Description

Additional file 5: Supplementary Table S10. List of annotated splicing events regulated by Pladienolide B, Indisulam and THZ531 in 22Rv1 cells compared to control (fold change >=2, p-value

Dati resi disponibili	2024
Editore	figshare

DOI
10.6084/m9.figshare.26685852

Accesso dataset

Creative Commons Attribution 4.0 International

Cita questo

DataSetCite

Naro, C. (Creatore), Antonioni, A. (Creatore), Medici, V. (Creatore), Caggiano, C. (Creatore), Jolly, A. (Creatore), de la Grange, P. (Creatore), Bielli, P. (Creatore), Paronetto, M. P. (Creatore), Sette, C. (Creatore) (2024). Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer. figshare. 10.6084/m9.figshare.26685852

Additional file 5 of Splicing targeting drugs highlight intron retention as an actionable vulnerability in advanced prostate cancer

Description

DOI

Accesso dataset

Cita questo